Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PULMOZYME
- PLEURAL IRRIGATION WITH NORMAL SALINE VERSUS INTRAPLEURAL FIBRINOLYTIC IN PLEURAL INFECTION
- Reduction of SystemiC Inflammation After Ischemic Stroke by Intravenous DNase Administration (ReSCInD)
- Improving Early Reperfusion With Adjuvant Dornase Alfa in Large Vessel Ischemic Stroke (EXTEND-IA DNase)
- Usefulness of DORNASE in COVID-19 on HFNO
- Short Duration High Intensity Intrapleural Alteplase With Pulmozyme in Pleural Infection Management
- Efficacy of Pulmozyme® on Arterial Recanalization in Post-thrombectomy Patients Managed for Ischemic Stroke (NETs-target)
- I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
- Dornase Alpha for the Treatment of COVID-19
- DISmantling COvid iNduced Neutrophil ExtraCellular Traps (DISCONNECT-1)
- Dornase Alfa for ARDS in Patients With Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
- Pulmozyme to Improve COVID-19 ARDS Outcomes
- Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection
- Fibrinolytic Therapy Versus Medical Thoracoscopy
- LC-MS/MS Based Method Development for the Monitoring of Antibiotic Concentrations in Sputum of Cystic Fibrosis Patients
- Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Exploratory Efficacy Parameters of AIR DNase™in Patients With Cystic Fibrosis Previously Treated With Pulmozyme®
- rhDNase Eye Drops in Patients With Ocular Graft-Vs.-Host Disease
- DNase Treatment for Dry Eyes
- A Study of the Comparable Efficacy and Safety of Pulmozyme (Dornase Alfa) Delivered by the eRapid Nebulizer System in Patients With Cystic Fibrosis
- Pulmozyme for Sjogren's Associated Cough
- Dornase Alfa Therapy for Ventilator Associated Lung Infections in the Neonatal Intensive Care Unit (NICU)
- Pulmozyme in Cystic Fibrosis With Sinusitis
- Impact of Nebulized Dornase Alpha on Mechanically Ventilated Patients
- RhDNase and Biodistribution of PMN Serine Proteases in Cystic Fibrosis Sputum
- A Study of Pulmozyme® (Dornase Alpha) in 3- to 5-Year-Old Patients With Cystic Fibrosis
- Pilot Study of Pulmozyme (rhDNase) in Patients With Head and Neck Cancers Treated With Radiation Therapy + Chemotherapy
- Nasal Inhalation of Pulmozyme in Patients With Cystic Fibrosis and Chronic Rhinosinusitis
- A Trial of Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis Subjects With Severe Lung Disease (TOPIC)
- Treatment of Clogged Tympanostomy Tubes: An Off-Label Use of Dornase Alfa (Pulmozyme®)
- Nasally Delivered Pulmozyme for Sinusitis in Cystic Fibrosis
- Nasal Inhalation of Dornase Alfa (Pulmozyme) in Patients With Cystic Fibrosis and Chronic Rhinosinusitis
- Effectiveness of Pulmozyme in Infants With Cystic Fibrosis
- Study of Pulmozyme to Treat Severe Asthma Episodes
- Comparison of Inhaled Mannitol and rhDNase in Children With Cystic Fibrosis
Clinical trials list
click for details